SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001477932-18-004818
Filing Date
2018-10-11
Accepted
2018-10-11 16:55:51
Documents
6
Effectiveness Date
2018-10-11

Document Format Files

Seq Description Document Type Size
1 FORM S-8 curr_s8.htm S-8 42098
2 OPINION curr_ex51.htm EX-5.1 5182
3 CONSENT curr_ex232.htm EX-23.2 1592
4 2017 EQUITY INCENTIVE PLAN curr_ex991.htm EX-99.1 234384
5 curr_ex51img1.jpg GRAPHIC 4640
6 curr_ex51img2.jpg GRAPHIC 4161
  Complete submission text file 0001477932-18-004818.txt   296700
Mailing Address 1620 BEACON PLACE OXNARD CA 93033
Business Address 1620 BEACON PLACE OXNARD CA 93033 805-824-0410
Cure Pharmaceutical Holding Corp. (Filer) CIK: 0001643301 (see all company filings)

IRS No.: 371765151 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-227791 | Film No.: 181118774
SIC: 2673 Plastics, Foil & Coated Paper Bags